Physician Perspectives on the Management of Patients with Resected High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck Who Are Ineligible to Receive Cisplatin: A Podcast.

It'd be really interesting to hear your perspectives around what you do when you have a patient, for instance, who develops quite significant toxicity on a high dose of platinum—maybe in cycle 1 you've given 100 mg/m 2 .

also in 5,695 other papers